# Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers

> **NCT02055365** · NA · COMPLETED · sponsor: **Rockefeller University** · enrollment: 10 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** Hepatitis B Vaccine (Recombinant)

## Key facts

- **NCT ID:** NCT02055365
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-18
- **Primary completion:** 2015-01-06
- **Final completion:** 2015-01-06
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02055365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02055365, "Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02055365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*